COMMUNIQUÉS West-GlobeNewswire

AGTC to Present at the Wedbush PacGrow Healthcare Conference on August 14, 2019
07/08/2019
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]
ProQR Announces Financial Results for the Second Quarter of 2019
07/08/2019
LEIDEN, Netherlands and CAMBRIDGE, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]
Trevena Reports Second Quarter 2019 Results
07/08/2019
— Enrollment for healthy volunteer QT study ongoing, topline data on schedule for Q4 2019 readout — — Company remains on track to resubmit NDA for oliceridine in Q1 2020 — — Cash runway as of June 30, 2019 continues to [...]
Natus Expands the Supporting Community of Otoscan
07/08/2019
Natus to continue their successful pilot program with Starkey Hearing Technologies PLEASANTON, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading [...]
Anavex Life Sciences Reports Fiscal 2019 Third Quarter Financial Results And Provides Clinical Study Updates
07/08/2019
Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing [...]
Surgery Partners, Inc. Announces Second Quarter 2019 Results
07/08/2019
BRENTWOOD, Tenn., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the second quarter [...]
Arcturus to Report Corporate Overview and Financial Results on August 15
07/08/2019
SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (NASDAQ: ARCT) (the “Company”), a leading messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics [...]
AMAG Pharmaceuticals Announces Second Quarter 2019 Financial Results and Provides Corporate Update
07/08/2019
Promoted products achieved sequential and year-over-year revenue and market share growth 2019 financial guidance lowered: exiting Makena intramuscular market and removing milestone revenue Vyleesi on-track for national [...]
Arvinas To Present at the Wedbush PacGrow Healthcare Conference
07/08/2019
NEW HAVEN, Conn. , Aug. 07, 2019 (GLOBE NEWSWIRE) -- Arvinas Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that the company is [...]
YSS Corp. Announces Receipt of Retail Cannabis Store License in Edmonton
07/08/2019
CALGARY, Alberta, Aug. 07, 2019 (GLOBE NEWSWIRE) -- YSS Corp.™ (the “ Company ” or “ YSS ”) (TSXV: YSS) (WKN: A2PMAX) is pleased to announce receipt of an additional cannabis retail license from the Alberta Gaming, [...]
Selecta Biosciences Combines ImmTOR™ Platform with AskBio’s Industry-Leading Gene Therapy Platform in Strategic Partnership
07/08/2019
Development pipeline and human trials planned for repeat dosing of AAV-based gene therapies to address the unmet medical need for patients with rare and orphan genetic diseases. WATERTOWN, Mass. and RESEARCH TRIANGLE [...]
Cyclacel Pharmaceuticals to Release Second Quarter 2019 Financial Results
07/08/2019
BERKELEY HEIGHTS, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]
Zomedica Announces TRUFORMA™ Assay Updates and R&D Expansion
07/08/2019
ANN ARBOR, Mich., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced additional development progress [...]
Madrigal Pharmaceuticals Reports 2019 Second Quarter Financial Results and Highlights
07/08/2019
-- Phase 3 MAESTRO-NASH Program Continues to Progress -- -- Jim Daly Added to Board of Directors and Becky Taub Promoted to President of R&D -- -- Madrigal Presentations Selected for the Liver Meeting ® AASLD 2019 [...]
Teleflex Wins New Zealand Innovation Award for UroLift System for Patients with Enlarged Prostate
07/08/2019
Minimally Invasive Treatment Provides Rapid, Durable Symptom Relief Without Compromising Sexual Function* WAYNE, Pa., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the UroLift ® [...]
Rexahn Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Update on RX-3117 Development
07/08/2019
ROCKVILLE, Md., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NasdaqCM: REXN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are [...]
KBP BioSciences Signs Memorandum of Understanding with BullFrog AI
07/08/2019
Envisions Using BullFrog AI Innovative Artificial Intelligence Technology to Expand KBP’s Diverse Product Pipeline PRINCETON, N.J. and JINAN, China, Aug. 07, 2019 (GLOBE NEWSWIRE) -- KBP BioSciences USA , a clinical [...]
Jounce Therapeutics Reports Second Quarter 2019 Financial Results
07/08/2019
- Initiated Phase 2 EMERGE trial of vopratelimab - - Completed enrollment of Phase 1 trial of JTX-4014 - - Updated strategic collaboration and established new licensing agreement with Celgene, received $50.0 million [...]
Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash
07/08/2019
EAST RUTHERFORD, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]

Pages